Evidence map›Paper›PMID 26535571›Full record

ArticlePloS one2015

(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression.

Jisu Park, Heesung Chung, Seung Hyun Bang, Ah-Reum Han, Eun-Kyoung Seo, Sung Eun Chang, Duk-Hee Kang, Eok-Soo Oh

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Antiphotoaging properties ofToxicological research · 2022
    Article
  2. Phytochemicals and Bioactivities ofMolecules (Basel, Switzerland) · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Pigmentation Effect of Rice Bran Extracted Minerals Comprising Soluble Silicic Acids.Evidence-based complementary and alternative medicine : eCAM · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jisu ParkDepartment of Life Sciences, the Research Center for Cellular Homeostasis, Ewha Womans University, Seoul, Korea.
Heesung ChungDepartment of Life Sciences, the Research Center for Cellular Homeostasis, Ewha Womans University, Seoul, Korea.
Seung Hyun BangDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Ah-Reum HanThe Global Top5 Research Program, College of Pharmacy, Ewha Womans University, Seoul, Korea.
Eun-Kyoung SeoThe Global Top5 Research Program, College of Pharmacy, Ewha Womans University, Seoul, Korea.
Sung Eun ChangDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Duk-Hee KangDivision of Nephrology, Department of Internal Medicine, Ewha Medical Research Center, Ewha Womans University School of Medicine, Seoul, Korea.
Eok-Soo OhDepartment of Life Sciences, the Research Center for Cellular Homeostasis, Ewha Womans University, Seoul, Korea.
Ewha Womans University · KRAsan Medical Center · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the potential melanogenic effect of compounds from Zingiber cassumunar Roxb. Our data revealed that chloroform-soluble extract of Z. cassumunar enhanced melanin synthesis in B16F10 melanoma cells. Among the components of the chloroform extract, (E)-4-(3,4-dimethoxyphenyl)but-3-en-1-ol (DMPB) increased melanogenesis in both B16F10 cells and human primary melanocytes. In B16F10 cells, DMPB enhanced the activation of ERK and p38, and the level of tyrosinase. Although the level of microphthalmia-associated transcription factor was unchanged in DMPB-treated B16F10 cells, DMPB increased levels and nuclear localization of upstream stimulating factor-1 (USF1). Consistently, DMPB-mediated melanin synthesis was diminished in USF1-knockdown cells. Furthermore, DMPB induced hyperpigmentation in brown guinea pigs in vivo. Together, these data suggest that DMPB may promote melanin synthesis via USF1 dependent fashion and could be used as a clinical therapeutic agent against hypopigmentation-associated diseases.

Indexed as

AnimalsButanolsCell Line, TumorCell ProliferationGene Expression RegulationGuinea PigsHumansLiquid-Liquid ExtractionMelaninsMelanocytesMethanolMiceMicrophthalmia-Associated Transcription FactorMicroscopy, FluorescenceMitogen-Activated Protein KinasesMonophenol Monooxygenase4-(3',4'-dimethoxyphenyl)but-3-en-1-olButanolsMelaninsMethanolMicrophthalmia-Associated Transcription FactorMitogen-Activated Protein KinasesMonophenol MonooxygenaseRNA, Small InterferingUpstream Stimulatory FactorsUsf1 protein, mouse

Identifiers

PMID26535571
PMCPMC4633108
OpenAlexW2102021824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.